CGEN-243

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCGEN-243
Drug Alias NameCGEN-243
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsAutoimmune DiseasesMultiple MyelomaLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesCompugen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCompugen Ltd
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesMultiple MyelomaLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A